UTHR

United Therapeutics Corporation (UTHR)

Last Price$365.0(0.4%)
Market Cap$16.2B
LTM EPS
$24.33
EPS growth
15.5%
Ben Graham Fair Value
$825.9
Undervalued (Ben Graham formula)
126.3%
Stock quality
8/10
Great

UTHR Ben Graham Fair Value

Crunching data... Almost there!

Best stock ideas on the market right now

With Value Sense, you can find undervalued stocks list with intrinsic value. Discover more stock market investment ideas.

UTHR EPS growth & Dividend Yield

Crunching data... Almost there!

UTHR vs Peer Set: Ben Graham Fair Value Comparison

Crunching data... Almost there!

Explore more intrinsic value tools hub for UTHR

Loved by
investors
worldwide
10K+
Investors use our platform
#1
Top value investing hub with all necessary tools
1K+
Experienced investors in our community
4.9
Average rating across all rating platforms

FAQ

What is United Therapeutics Corporation's fair value according to the Ben Graham formula?

As of Sep 30, 2024, United Therapeutics Corporation's fair value using the Ben Graham formula is $825.9 per share. This is calculated using Ben Graham formula, where EPS is $24.3 and BVPS (Book Value Per Share) is $133.5. The current price of $365.0 suggests United Therapeutics Corporation may be overvalued by this conservative metric.

What is United Therapeutics Corporation earnings per share (EPS)?

United Therapeutics Corporation earnings per share (EPS) for the twelve months ending Sep 30, 2024, was $24.3, a 15.5% growth year-over-year.

What is United Therapeutics Corporation's margin of safety based on the Ben Graham analysis?

United Therapeutics Corporation's margin of safety is positive 126.3%, calculated as (Graham Number - Current Price) / Current Price. A negative margin of safety suggests the stock doesn't provide the level of safety Graham typically sought in his investments.